83 related articles for article (PubMed ID: 10226796)
1. IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement.
Winkler R; Delacroix L; Bensbaho K; Lambert S; Collette J; Hodzic D
Horm Metab Res; 1999; 31(2-3):148-54. PubMed ID: 10226796
[TBL] [Abstract][Full Text] [Related]
2. Cloning of breakpoints in and downstream the IGF2 gene that are associated with overexpression of IGF2 transcripts in colorectal tumours.
Hodzic D; Frey B; Marechal D; Scarcez T; Grooteclaes M; Winkler R
Oncogene; 1999 Aug; 18(33):4710-7. PubMed ID: 10467418
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma.
Hodzic D; Delacroix L; Willemsen P; Bensbaho K; Collette J; Broux R; Lefèbvre P; Legros JJ; Grooteclaes M; Winkler R
Horm Metab Res; 1997 Nov; 29(11):549-55. PubMed ID: 9479554
[TBL] [Abstract][Full Text] [Related]
4. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
5. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues.
Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB
Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946
[TBL] [Abstract][Full Text] [Related]
6. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
[TBL] [Abstract][Full Text] [Related]
7. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW
Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246
[TBL] [Abstract][Full Text] [Related]
8. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
[TBL] [Abstract][Full Text] [Related]
9. [Insulin-like growth factor 2 imprinting status and promoter usage in the placenta of macrosomia].
Yao JC; Hu YL; Wang ZQ; Dai YM; Ling JX; Ye XD
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):309-14. PubMed ID: 17673042
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of insulin-like growth factor (IGF-I and IGF-II) genes in human tumor tissue.
Schneid H; Seurin D; Noguiez P; Le Bouc Y
Growth Regul; 1992 Mar; 2(1):45-54. PubMed ID: 1362510
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
[TBL] [Abstract][Full Text] [Related]
12. Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon.
Mineo R; Fichera E; Liang SJ; Fujita-Yamaguchi Y
Biochem Biophys Res Commun; 2000 Feb; 268(3):886-92. PubMed ID: 10679300
[TBL] [Abstract][Full Text] [Related]
13. A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues.
Fichera E; Liang S; Xu Z; Guo N; Mineo R; Fujita-Yamaguchi Y
Growth Horm IGF Res; 2000 Apr; 10(2):61-70. PubMed ID: 10931743
[TBL] [Abstract][Full Text] [Related]
14. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not.
Okazaki R; Conover CA; Harris SA; Spelsberg TC; Riggs BL
J Bone Miner Res; 1995 May; 10(5):788-95. PubMed ID: 7639114
[TBL] [Abstract][Full Text] [Related]
15. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
16. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
Vu TH; Hoffman AR
Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
[TBL] [Abstract][Full Text] [Related]
17. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
18. Expression and CpG methylation of the insulin-like growth factor II gene in human smooth muscle tumors.
Gloudemans T; Pospiech I; Van Der Ven LT; Lips CJ; Schneid H; Den Otter W; Sussenbach JS
Cancer Res; 1992 Dec; 52(23):6516-21. PubMed ID: 1358435
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor gene expression in human smooth muscle tumors.
Gloudemans T; Prinsen I; Van Unnik JA; Lips CJ; Den Otter W; Sussenbach JS
Cancer Res; 1990 Oct; 50(20):6689-95. PubMed ID: 2208134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
